CA 15-3 as a tumor marker in gynecological malignancies
- 1 June 1988
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 30 (2), 265-273
- https://doi.org/10.1016/0090-8258(88)90032-7
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Serum CA 125 levels in epithelial ovarian cancer: relation with findings at second‐look operations and their role in the detection of tumour recurrenceBJOG: An International Journal of Obstetrics and Gynaecology, 1987
- Serum CA 125 in epithelial ovarian cancer. A longitudinal studyBJOG: An International Journal of Obstetrics and Gynaecology, 1987
- CA 125 in gynecologic practiceAmerican Journal of Obstetrics and Gynecology, 1986
- CA 125 Serum Levels Correlated With Second-Look Operations Among Ovarian Cancer PatientsObstetrics & Gynecology, 1986
- Elevation of serum CA125 in carcinomas of the fallopian tube, endometrium, and endocervixAmerican Journal of Obstetrics and Gynecology, 1984
- Monoclonal Antibodies against Human Milkfat Globule Membranes Useful in Carcinoma ResearchPublished by Elsevier ,1984
- A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian CancerNew England Journal of Medicine, 1983
- A survey of tumor markers in patients with squamous cell carcinoma of the uterine cervixGynecologic Oncology, 1982
- Immunohistochemical Localisation of Alpha-Fetoprotein (AFP) in Germ Cell Tumours: Evidence for AFP Production by Tissues Different from Endodermal Sinus TumourOncology, 1981
- Multiple biochemical markers in patients with gynecologic malignanciesCancer, 1980